Gene Expression Study Between Two Dermal Injectables Hydroxylapatite Semi-permanent Filler
Clinical trial NCT05620043 · COMPLETED
Trial details
- NCT number
- NCT05620043
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-28
- Primary completion
- 2023-07-25
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.